Loretto Callaghan is an experienced non-executive director with country leadership, executive leadership, and board directorship experience in the Biopharmaceutical / Healthcare sector. In her most recent role, she was CEO and Country President of Novartis in Ireland where she led a series of organisational restructures, and culture and business model transformations. She also served as Chair and executive director of the Irish Subsidiary board of Novartis AG, was a board member of the Irish Pharmaceutical Healthcare Association (IPHA) and Chair of the IPHA Brexit Group.
Loretto Callaghan holds a M.Sc. from Trinity College, Dublin, and a B.Sc. from University College Dublin and has studied Healthcare Systems at the Harvard School of Public Health. She is a Chartered Director with the UK Institute of Directors and is a member of the Governance Advisory Council of the Corporate Governance Institute.